Search

Your search keyword '"Miro, Jose M."' showing total 862 results

Search Constraints

Start Over You searched for: Author "Miro, Jose M." Remove constraint Author: "Miro, Jose M."
862 results on '"Miro, Jose M."'

Search Results

1. The hidden side of infective endocarditis: Diagnostic and management of 500 consecutive cases in noncardiac surgery centers (2009–2018)

2. Impact of interrupting antiretroviral therapy started during primary HIV-1 infection on plasma neurofilament light chain protein, a marker of neuronal injury: The SPARTAC trial

3. Major cardiovascular events after COVID-19 in people with HIV

6. Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

9. Integrase strand-transfer inhibitor use and cardiovascular events in adults with HIV: an emulation of target trials in the HIV-CAUSAL Collaboration and the Antiretroviral Therapy Cohort Collaboration

14. High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial

15. Overview of SARS-CoV-2 infection in adults living with HIV

16. Immunological and virological findings in a patient with exceptional post-treatment control: a case report

18. Infective Endocarditis in Patients on Chronic Hemodialysis

19. Emulating a trial of joint dynamic strategies: An application to monitoring and treatment of HIV‐positive individuals

20. Daptomycin Dose-Ranging Evaluation with Single-Dose versus Multidose Ceftriaxone Combinations against Streptococcus mitis/oralis in an Ex Vivo Simulated Endocarditis Vegetation Model.

21. Mutations in cdsA and pgsA Correlate with Daptomycin Resistance in Streptococcus mitis and S. oralis.

22. Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium

23. HIV replication and tuberculosis risk among people living with HIV in Europe: A multicohort analysis, 1983–2015.

24. External Validation of the 2023 Duke–International Society for Cardiovascular Infectious Diseases Diagnostic Criteria for Infective Endocarditis

25. Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study

26. Contemporary antiretrovirals and body-mass index: a prospective study of the RESPOND cohort consortium

27. No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/[micro]L

30. Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study

31. Comparison of dynamic monitoring strategies based on CD4 cell counts in virally suppressed, HIV-positive individuals on combination antiretroviral therapy in high-income countries: a prospective, observational study

32. Perturbations of Phosphatidate Cytidylyltransferase (CdsA) Mediate Daptomycin Resistance in Streptococcus mitis/oralis by a Novel Mechanism

33. Gentamicin may have no effect on mortality of staphylococcal prosthetic valve endocarditis

36. Reply to Author

37. Reply to Garcia-Granja et al

40. Leishmaniasis and HIV

41. Role of age and comorbidities in mortality of patients with infective endocarditis

42. Therapeutic Vaccination Refocuses T-cell Responses Towards Conserved Regions of HIV-1 in Early Treated Individuals (BCN 01 study)

43. Analysis of the costs and cost-effectiveness of the guidelines recommended by the 2018 GESIDA/Spanish National AIDS Plan for initial antiretroviral therapy in HIV-infected adults

44. Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2018)

47. Risk factors of pericardial effusion in native valve infective endocarditis and its influence on outcome: A multicenter prospective cohort study

49. Multilocus microsatellite genotyping array for investigation of genetic epidemiology of Pneumocystis jirovecii.

50. External Validation of the 2023 Duke–International Society for Cardiovascular Infectious Diseases Diagnostic Criteria for Infective Endocarditis.

Catalog

Books, media, physical & digital resources